Nightingale Health
Egetis attracts a bid and agrees to sell its priority review voucher, Lytix meets its endpoint in melanoma and Novo raises its outlook – the Nordic Pulse | 2026:45
Xbrane clears the FDA, BioInvent seeks 430 Mkr and Genmab keeps surging – the Nordic Pulse | 2026:44
Analytics
Egetis wins FDA approval, Indices retreat across the board – the Nordic Pulse | 2026:40
Nanexa lands billion-euro Novo deal, Nordic index slides nearly three per cent – the Nordic Pulse | 2026:39
